NCT02376803View on ClinicalTrials.gov

"The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT"

PHASE4CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

April 27, 2018

Conditions
Atrial FibrillationThrombus Due to Heart Valve ProsthesisDeep Venous ThrombosisThromboembolismDVT
Interventions
DRUG

Warfarin

Morning vs Evening administration

Trial Locations (2)

T6G 2C8

University of Alberta, Edmonton

V5Z 1M9

Vancouver Coastal Health Research Institute, Vancouver

All Listed Sponsors
collaborator

Vancouver Coastal Health Research Institute

OTHER

lead

University of Alberta

OTHER

NCT02376803 - "The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT" | Biotech Hunter | Biotech Hunter